New immunosuppressive drugs in transplantation.
Groth
C G
CG
Department of Transplantation Surgery, Huddinge Hospital, Uppsala, Sweden.
Ohlman
S
S
Gannedahl
G
G
Ericzon
B G
BG
D001713:Biphenyl Compounds / Q000627:therapeutic use / Q000633:toxicity; D003524:Cyclosporins / Q000627:therapeutic use / Q000633:toxicity; D006146:Guanidines / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use* / Q000633:toxicity; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use / Q000633:toxicity; D011090:Polyenes / Q000627:therapeutic use / Q000633:toxicity; D020123:Sirolimus; D013601:T-Lymphocytes / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use / Q000633:toxicity; D014181:Transplantation Immunology; D011798:Quinaldines
D001713:Biphenyl Compounds; D003524:Cyclosporins; D006146:Guanidines; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011090:Polyenes; D020123:Sirolimus; D016559:Tacrolimus; C082770:IMM 125; C046943:brequinar; D011798:Quinaldines; C037258:gusperimus